HumaDX has completed the Pre-A round financing of tens of millions RMB

2023-04-11 10:24


Nanjing HumaDX Tech Co., Ltd., the parent company of Beijing HumaDX Tech Co., Ltd. (hereinafter referred to as "HumaDX"), has recently completed the Pre-A round financing of tens of millions of yuan. This round of financing is exclusively invested by Nanjing Jiangbei Science Investment Fund Qiruiyoukang, a subordinate of INNOVATION VENTURES. The financing fund will be used for the registration and application of the full-automatic multiplex flow fluorescence detection platform and supporting reagents made by HumaDX, the construction of the new production base and the expansion of the R&D team.

Mr. Dongqi Li, the founder of HumaDX, said that HumaDX focused on the research and development and production of full-automatic multiplex flow fluorescence instruments and supporting reagents, and possessed relatively complete capabilities in various fields. Within five years, the core team has made breakthroughs in the field of material science. First, it mastered the core technology of multiplex encoded magnetic microspheres; second, it developed the R&D and integration capability of automatic systems including the multiplex flow fluorescence detection module; third, it developed the capability for continuous R&D of reagent pipeline and the development of new indicators with great clinical significance; and finally, it possessed the capability for marketing and academic promotion. A future competitive IVD company should have the underlying scientific capabilities, reagents and instruments R&D and production capacity as the intermediate layer, as well as the marketing and academic promotion capabilities as the upper layer. Therefore, the team’s comprehensive competence is outstanding, and the company's short-term goal is to be the leader in the multiplex flow fluorescence field.